The degeneration of cholinergic neurons in the basal forebrain and decreased abundance and activity of choline acetyltransferase (ChAT), the enzyme that synthesizes acetylcholine in the presynaptic terminal, are the fundamental causes of reduced acetylcholine neurotransmission in AD patients. Here, CHAT is linked to Alzheimer disease.